Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_382ccfc2ebebcaee15aa7cda4cee86bc |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-497 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-497 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18 |
filingDate |
2007-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1bab6b76ccd643666362380626742cc8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3dfde226634f0059136189d447e2d532 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc8c29f5ce50b3cbf4f43d2fcfd72faf http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fc08ae61cdacf12d166a3e1d40df1ed3 |
publicationDate |
2008-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2008107745-A1 |
titleOfInvention |
Controlled release sterile injectable aripiprazole formulation and method |
abstract |
A controlled release sterile freeze-dried aripiprazole formulation is provided which is formed of aripiprazole of a desired mean particle size and a vehicle therefor, which upon constitution with water and intramuscular injection releases aripiprazole over a period of at least about one week and up to about eight weeks. A method for preparing the controlled release freeze-dried aripiprazole formulation, and a method for treating schizophrenia employing the above formulation are also provided. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9457026-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008112986-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9763935-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108379231-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010196486-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8030313-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8722679-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11786522-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8952013-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2008221121-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019070171-A1 |
priorityDate |
2003-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |